Significance of cytotoxic activity of peripheral blood lymphocytes against autologous tumor cells in patients with bladder cancer

Cancer Biotherapy and Radiopharmaceuticals

Volumn 11, Issue 6, 1996, Pages 385-391

  Mizutani, Youichi ^a   Okada, Yusaku ^a   Yoshida, Osamu ^a   Bonavida, Benjamin ^b  

^a KYOTO UNIVERSITY   (Japan)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Autologous tumor; Bladder cancer; Cell mediated cytotoxicity; K562; T24

Indexed keywords

CHROMIUM 51;

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER CELL CULTURE; CELLULAR IMMUNITY; CHROMIUM 51 RELEASE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; EFFECTOR CELL; FEMALE; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; MAJOR CLINICAL STUDY; MALE; NATURAL KILLER CELL; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; TARGET CELL DESTRUCTION; TUMOR CELL DESTRUCTION;

EID: 0030471044     PISSN: 10849785     EISSN: None     Source Type: Journal    
DOI: 10.1089/cbr.1996.11.385     Document Type: Article

References (23)

1. Mizutani Y, Nio Y, Fukumoto M, Yoshida O. Effects of bacillus Calmette-Guerin on cytotoxic activities of peripheral blood lymphocytes against human T24 lined and freshly isolated autologous urinary bladder transitional carcinoma cells in patients urinary bladder cancer. Cancer 1992;69:537-545.
2. Shapiro A, Ratliff TL, Oakley DM, Catalona WJ. Reduction of bladder tumor growth in mice treated with intravesical Bacillus Calmette-Guenn and its correlation with Bacillus Calmette-Guerin viability and natural killer activity. Cancer Res 1983;47:1611-1617.
3. Takasugi M, Mickey MR, Terasaki PI. Reactivity of lymphocytes from normal persons on cultured tumor cells. Cancer Res 1973;33:2898-2902
4. Peter HJ, Pavie-Fisher J, Fridman W, Aubert C, Cesarini JP, Roubin R, Kourilsky F. Cell-mediated cytotoxicity in vitro of human lymphocytes against a tissue culture melanoma cell line J Immunol 1975;115 39-44.
5. Herberman RB, Ortaldo JR. Natural killer cells : Their role in defenses against disease. Science 1981;214:24-30.
6. Haller O, Hausson M, Kiessling R, Wizzell G. Role of non-conventional natural killer cell resistance against syngeneic tumor cells in vivo. Nature 1977;270:609-611.
7. Baldwin RW. Immune surveillance revisited. Nature 1977;270:557.
8. Ritz J. The role of natural killer cells in immune surveillance. N Eng J Med 1989;320:1748-1749.
9. Mizutani Y, Okada Y, Terachi T, Yoshida O Prognostic significance of circulating cytotoxic lymphocytes against autologous tumors in patients with urinary bladder cancer. J Urol 1996;155:888-894.
10. Becker S, Kiessling R, Leen N, Klein G. Modulation of sensitivity to natural killer cell lysis after in vitro explanation of a mouse lymphoma. J Natl Cancer Inst 1978;61:1495-1498.
11. Uchida A, Mizutani Y. Autologous tumor killing activity in human. Mechanisms and biological significance. In: Torisu Y, Yoshida T, eds New horizons in tumor immunotherapy. Amsterdam: Elsevier Science Publishers, 1989:201-213.
12. Mizutani Y, Nio Y, Bonavida B, Yoshida O. Enhanced susceptibility of cis-diamminedichloroplatinum-treated K562 cells to lysis by peripheral blood lymphocytes and lymphokine activated killer cells Cancer 1993;71:1313-1321.
13. Mizutani Y. Nio Y, Yoshida O. The streptococcal preparation OK-432 specifically augments the susceptibility of human urinary bladder tumor cells to the autologous peripheral blood lymphocytes. Cancer 1992;69:2999-3007.
14. Mizutani Y, Bonavida B, Koishihara Y, Akamatsu K, Ohsugi Y, Yoshida O. Sensitization of human renal cell carcinoma cells to cis-diamminedichloroplatinum (II) by anti-IL-6 monoclonal antibody or anti-IL-6 receptor monoclonal antibody. Cancer Res 1995;55:590-596.
15. Mizutani Y, Fukumoto M, Bonavida B, Yoshida O. Enhancement of sensitivity of urinary bladder tumor cells to cisplatin by c-myc antisense oligonucleotide. Cancer 1994;74:2546-2554.
16. Bubenik K, Bresova M, Viklicky V, Jakoubkova J, Sainerova H, Donner J. Established cell line of urinary bladder carcinoma (T24) containing tumor-specific antigen. Int J Cancer 1973;11:765-771.
17. Mizutani Y, Nio Y, Yoshida O. Modulation by cis-diamminedichioroplatinum (II) (CDDP) of the susceptibilities of human T24 lined and freshly separated autologous urinary bladder transitional carcinoma cells to blood natural killer (NK) cells and lymphokine activated killer (LAK) cells. J Urol 1992;147:505-510.
18. Mizutani Y, Nio Y, Yoshida O. Effect of PSK and its subfractions on peripheral blood lymphocytes mediated cytotoxicity against urinary bladder tumor cells. J Urol 1992;148:1571-1576.
19. Troye M, Perlmann P, Larsson A, Blomgren H, Johansson B. Cellular cytotoxicity in vitro in transitional cell carcinoma of the human urinary bladder: Cr-release assay. Int J Cancer 1977;20:188-198.
20. Moore M, Robinson N. Cell-mediated cytotoxicity in carcinoma of the human urinary bladder. Cancer Immunol Immunother 1977;2:233-243.
21. Carballido J, Alvarez-Mon M, Solovera J, Menendez-Ondina L, Dyrantez A. Clinical significance of natural killer activity in patients with transitional cell carcinoma of the bladder. J Urol 1990;143:29-33.
22. Monta T, Tokue A, Minato N. Analysis of natural killer activity and natural killer cell subsets in patients with bladder cancer Cancer Immunol Immunother 1990;32:191-194.
23. Ma CP, Yu DS, Yeh MY, Cjang SY, Han SH Natural killer cell activity in patients with urologic cancer Eur Urol 1987;13:397-400.